Critical Therapeutics Announces Beckman Coulter Exercises Option ... - Genetic Engineering News (press release)
February 13, 2007| Critical Therapeutics Announces Beckman Coulter Exercises Option ... Genetic Engineering News (press release), NY - Critical Therapeutics exclusively licensed its HMGB1 patent estate for the treatment and prevention of diseases to MedImmune in 2003. ... |
Human Genome Sciences and GlaxoSmithKline Announce Initiation of ... - Yahoo! News (press release)
February 13, 2007| Human Genome Sciences and GlaxoSmithKline Announce Initiation of ... Yahoo! News (press release) - In lupus, rheumatoid arthritis, and certain other autoimmune diseases, elevated levels of BLyS are believed to contribute to the production of ... New hope for lupus patients Human Genome Brings Lupus Drug to Clinical Trial |